Kuemmel S, Campone M, Loirat D, Lopez Lopez R, et al. A Randomized Phase II Study of Anti-CSF-1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple Negative Breast Cancer. Clin Cancer Res 2021 Oct 6. pii: 1078-0432.CCR-20-3955.
PMID: 34615719